
Alphavog GM 1mg/500mg/0.3mg Tablet
Marketer
Proqol Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Alphavog GM 1mg/500mg/0.3mg Tablet
Diabetol-Triple 1mg/500mg/0.3mg tablets are classified as anti-diabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose. Consistent blood sugar control is achieved through regular daily intake, ideally with meals, at the same time each day. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect. Familiarize yourself with its symptoms—sweating, dizziness, headache, trembling—and how to address them. Consistent meals and readily available fast-acting glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be minimized. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Routine blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Alphavog GM 1mg/500mg/0.3mg Tablet
The provided text is "undefined," so no rephrasing is possible.
Uses of Alphavog GM 1mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Alphavog GM 1mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Alphavog GM 1mg/500mg/0.3mg tablets on an empty stomach.
Common Side effects of Alphavog GM 1mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Alphavog GM 1mg/500mg/0.3mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Alphavog GM 1mg/500mg/0.3mg Tablets should be taken on an empty stomach.
How Alphavog GM 1mg/500mg/0.3mg Tablet works:
Each Alphavog GM tablet (1mg/500mg/0.3mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Alphavog GM 1mg/500mg/0.3mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Alphavog GM 1mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any hazards before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Alphavog GM 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if these conditions arise.
KidneyUNSAFE
Alphavog GM 1mg/500mg/0.3mg Tablets pose a likely risk for individuals with kidney impairment and should be omitted. Physician consultation is advised. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Alphavog GM 1mg/500mg/0.3mg tablets cautiously, as dosage modification may be necessary. Individuals with severe hepatic dysfunction should avoid this medication. A reduced initial dose is generally advised for patients with mild to moderate liver disease. Physician consultation is recommended.
What if you forget to take Alphavog GM 1mg/500mg/0.3mg Tablet :
Should you forget to take a dose of Alphavog GM 1mg/500mg/0.3mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Alphavog GM 1mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
